Related content

Enhanced efficacy of repeated anti-NCD8 monoclonal antibody therapy by high-dose cyclosporine treatment

By Allan J.S.   Slisz J.K.   Vesga L.   Arn J.S.   Yamada K.   Sachs D.H.   Madsen J.C.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4062-4063

Elsevier

Access to resources Recommend Favorite

Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma

By Medeiros B.C.   Kogel K.E.   Kane M.A.  

Transfusion and Apheresis Science, Vol. 29, Iss. 1, 2003-08 ,pp. : 25-27

Elsevier

Access to resources Recommend Favorite

Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group

By Puig i Mar J.M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2256-2258

Elsevier

Access to resources Recommend Favorite

High-Dose Cellular IL-10 Exacerbates Rejection and Reverses Effects of Cyclosporine and Tacrolimus in Mouse Cardiac Transplantation

By Li W.   Lu L.   Li Y.   Fu F.   Fung J.J.   Thomson A.W.   Qian S.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1081-1082

Elsevier

Access to resources Recommend Favorite

CliniMACS CD34-selected cells to support high-dose therapy

By Prince H.M.   Wall D.   Chapple P.   Quinn M.   Brettell M.   Haylock D.   Seymour J.F.   Wolf M.   Januscewicz H.   Richardson G.   Joyce T.   Maisano R.   Rischin D.  

Transfusion and Apheresis Science, Vol. 24, Iss. 2, 2001-04 ,pp. : 183-183

Elsevier

Access to resources Recommend Favorite